| 1 |
25273829 | Men with lower HDL cholesterol levels have significant increment of soluble CD40 ligand and high-sensitivity CRP levels following the cessation of long-term clopidogrel therapy. | 2015 |
1 |
| 2 |
26156883 | Effect of P2Y12 inhibitors on inflammation and immunity. | 2015 Aug 31 |
1 |
| 3 |
24469880 | Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study. | 2013 |
1 |
| 4 |
19855266 | Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. | 2010 Jan-Feb |
1 |
| 5 |
20069077 | PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. | 2009 |
2 |
| 6 |
14730251 | Role of inflammation in stroke and atherothrombosis. | 2004 |
2 |
| 7 |
15019868 | Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. | 2004 Mar 15 |
1 |
| 8 |
15280513 | CD40 ligand: a novel target in the fight against cardiovascular disease. | 2004 Sep |
1 |
| 9 |
15487851 | [Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel]. | 2004 Aug 15 |
1 |
| 10 |
11297035 | Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel. | 2001 Mar |
3 |